The article discusses funding for technology development. The author argues that potentially life-changing technologies, such as personalized drugs, lack support and discusses ways to change this. Topics include the lack of funding and effort in the path from laboratory to marketplace, the cost of developing the iPhone assistant, Siri, the legacy of big corporate laboratories in supporting research and development (R&D), and the role of private-public partnerships.
© 2001-2025 Fundación Dialnet · Todos los derechos reservados